In Brief This Week: Miraculins; Biomoda; Ontario Institute for Cancer Research; Abcodia; Massachusetts Life Sciences Center | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Miraculins this week said that it has received gross proceeds of C$554,000 (US$569,000) from the exercise of 5,540,000 warrants through its previously announced warrant exercise incentive program. The firm launched the early-exercise program last month and had targeted the early exercise of up to 7.8 million of its outstanding unlisted warrants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.